Actual Medicinal Product (AMP) -
Cancidas 50mg powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd)
Name Details
|
Current Name
Cancidas 50mg powder for concentrate for solution for infusion vials
|
Start Date
17-11-2023
|
End Date
|
|
Previous Name
Cancidas 50mg powder for solution for infusion vials
|
Start Date
14-01-2009
|
End Date
16-11-2023
|
|
|
Abbreviated Name
Cancidas 50mg pdr for concentrate for inf vials
|
Start Date
17-11-2023
|
|
Summary
- Licensed Route
- Intravenous
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF |
|
Previous BNF
05020400
|
Start Date
05-11-2010
|
End Date
03-04-2022
|
|
Previous BNF
05020000
|
Start Date
20-06-2005
|
End Date
04-11-2010
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 4847311000001104 |
04-09-2003 |
|
Actual Medicinal Product Pack (AMPP) Information